Conference attendees are invited to be part of the programme by submitting abstracts for poster presentation. The abstracts will be evaluated anonymously by a panel of experts and prizes will be given to those judged to be the best. 

The abstracts summarising your research should be no more than 300 words and submitted in Word format with the names and affiliations of all authors. Abstracts presented at other conferences and events are welcome. 

We are accepting abstracts up until Friday 26 April 2019 via email, on a first come, first served basis. Once you have submitted, you will receive an email acknowledgement to confirm that your abstract has been received. You will then be contacted to confirm whether or not you have been selected to present a poster. All notifications will be sent by Friday 17 May 2019.

All accepted abstracts will be published in Journal of Immunotherapy and Precision Oncology alongside the conference proceedings, and the authors will be offered an expedited review process if they choose to submit their full manuscript to JIPO.

If you have any queries regarding abstract submission please contact us.

The Journal of Immunotherapy and Precision Oncology (JIPO) isa high-quality, peer-reviewed publication that appeals to a broad readership of healthcare professionals and scientists, especiallythose with an interest in oncology and immunology. The Journal publishes innovative original research articles including translational science and clinical medicine, systematic and narrative reviews, letters, case reports, and invited editorials and commentaries from experts in the field. JIPO is an open access journal published quarterly.